Personalized Medicine:
Breaking Down the Barriers and Achieving Results

Agenda

7:30 a.m. Registration/Continental Breakfast/Networking
8:00 a.m.

Welcoming Remarks

David Resnick, Partner
Nixon Peabody LLP

8:15 a.m.

Keynote Address

Felix W. Frueh, PhD, Associate Director for Genomics
Office of Clinical Pharmacology and Biopharmaceutics, CDER/FDA
Presentation: Personalized Medicine—Quo Vadis?

8:50 a.m.

The Current State of Personalized Medicine

Moderator:
Edward Abrahams, Executive Director,
Personalized Medicine Coalition

Panelists:
J. Russell Teagarden MPH, RPH,
Vice President, Clinical Practice
Medco Health Solutions, Inc.
Presentation: Personalized Medicine in Pharmacy Benefits

Linda McAllister MD, PhD,
Director, Technology Management
U.S. Chief Technology Office
Roche Diagnostics

Keith Batchelder, MD, Founder and CEO
Genomic Healthcare Strategies
Presentation: The Current State of Personalized Medicine

9:40 a.m. Break
10:10 a.m.

What Problems Have to Be Solved?

Moderator:
Fintan Steele, Senior Vice President, Molecular Medicine
Feinstein Kean Healthcare

Panelists:
Lita Nelsen, Director
MIT Technology Licensing Office
Presentation: Personalized Medicine and University Technology Transfer

David Resnick, Partner
Nixon Peabody
Presentation: IP and Public Perception

David Lester, PhD, SVP, Strategy and Corporate Development
Gene Express, Inc.

11:00 a.m.

Where Is the Money Going?

Moderator:
Peter Miller, COO
Genomic Healthcare Strategies

Panelists:
Linda Grais, M.D., Partner,
InterWest Partners

Bruce Booth, Principal,
Atlas Venture

Jim Saalfield, Managing General Partner,
Still River Funds

12:00 p.m.

Lunch

Discussion with Patrice M. Milos, PhD,
Vice President & Chief Scientific Officer
Helicos BioSciences Corporation
Presentation: Are the Stars Aligned for Personalized Healthcare to Become a Reality?

1:10 p.m.

Diagnostics Company/Case Study

Moderator:
Mark Trusheim, President
Co-BIO Consulting

Panelists:
Marsha A. Moses, Ph.D. (Co-Founder)
Professor, Harvard Medical School and Children’s Hospital Boston,
Predictive Biosciences

Michael Greeley, General Partner,
IDG Ventures

Eugene Chiu
Co-Founder and Vice President of Business Development
Predictive Bioscience

2:10 p.m.

What the Future Holds

Moderator:
Keith Batchelder, MD, Founder & CEO
Genomic Healthcare Strategies

Panelists:
Mari Baker, President and CEO
Navigenics

Jason Bobe,
Harvard George Church Personal Genome Project
Presentation: What the Future Holds

Peter Miller, COO
Genomic Healthcare Strategies
Presentation: What the Future Holds

3:00 p.m.

Concluding Remarks

Keith Batchelder, Founder & CEO
Genomic Healthcare Strategies

3:15 p.m. Refreshments and Networking